A Pharmacovigilance Evaluation And Assessment Of The Prescribing Practice For Tygacil [tigecycline] In Usual Health Care Setting.

Trial Profile

A Pharmacovigilance Evaluation And Assessment Of The Prescribing Practice For Tygacil [tigecycline] In Usual Health Care Setting.

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Jul 2011

At a glance

  • Drugs Tigecycline (Primary)
  • Indications Bacterial infections; Intra-abdominal infections; Skin infections
  • Focus Therapeutic Use
  • Sponsors Pfizer; Wyeth
  • Most Recent Events

    • 24 Nov 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
    • 24 Nov 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Nov 2010 Planned number of patients changed to 1028 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top